Scholarlink

Introduction <p>Risperidone oral solution should not be administered in diluted form, as its active content may decrease when mixed with tea-extracted beverages. However, information regarding the actual administration practices among patients routinely using this medication remains unclear.</p> Objective <p>In this study, we aimed to investigate the real-world administration practices of risperidone oral solution, with a focus on whether patients or medication administrators dilute the solution in beverages.</p> Methods <p>A questionnaire survey was conducted among patients routinely using risperidone oral solution and their medication administrators who visited pharmacies in the Tohoku region of Japan.</p> Results <p>Overall, 22.6% of respondents reported occasionally mixing the solution with beverages. No significant difference was observed in the percentage of mixing with beverages between the brand-name and generic drugs. However, a significant age-related difference was noted: participants aged ≥ 60 years were more likely to mix the solution with beverages than those aged &lt; 60 years. Tea and cola—beverages with which risperidone should not be mixed—were also identified among the responses.</p> Conclusions <p>These findings highlight that the practice of mixing risperidone oral solution with inappropriate beverages is concerning and must be addressed. It is necessary to prevent the decline in risperidone content by gathering reliable drug information and offering personalized medication guidance.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Investigation of risperidone oral solution administration practices and risk of beverage-related drug interactions in Japanese patients

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年11月4日

查看全文
  • Yosuke Nishikawa,
  • Hiroyuki Suzuki,
  • Shiho Jinbayashi,
  • Naho Sato,
  • Kensuke Usui,
  • Kouji Okada,
  • Shinnosuke Kawai,
  • Kaori Ohmukai,
  • Yuriko Murai

摘要

Introduction

Risperidone oral solution should not be administered in diluted form, as its active content may decrease when mixed with tea-extracted beverages. However, information regarding the actual administration practices among patients routinely using this medication remains unclear.

Objective

In this study, we aimed to investigate the real-world administration practices of risperidone oral solution, with a focus on whether patients or medication administrators dilute the solution in beverages.

Methods

A questionnaire survey was conducted among patients routinely using risperidone oral solution and their medication administrators who visited pharmacies in the Tohoku region of Japan.

Results

Overall, 22.6% of respondents reported occasionally mixing the solution with beverages. No significant difference was observed in the percentage of mixing with beverages between the brand-name and generic drugs. However, a significant age-related difference was noted: participants aged ≥ 60 years were more likely to mix the solution with beverages than those aged < 60 years. Tea and cola—beverages with which risperidone should not be mixed—were also identified among the responses.

Conclusions

These findings highlight that the practice of mixing risperidone oral solution with inappropriate beverages is concerning and must be addressed. It is necessary to prevent the decline in risperidone content by gathering reliable drug information and offering personalized medication guidance.